Genetic Analysis of African-Americans With High Blood Pressure
2 other identifiers
observational
1,000
1 country
1
Brief Summary
The purpose of this study is to learn if kinase, a protein found in the heart, contributes to thickening of the heart muscle in people with high blood pressure. A protein called myosin causes the heart to contract and relax. It is thought that kinase changes myosin to make it work better at different heart rates. This study will try to determine if, in some people with high blood pressure, the different forms of this protein cause changes in the heart. If the protein affects the size of the heart, it might be possible to use it to improve heart function after an injury, such as a heart attack. African-Americans with high blood pressure will be eligible for this study. Current data show that of almost 900 multi-ethnic individuals, the particular form of kinase under study in this project is found exclusively in the African-American population. Study participants will have two tubes of blood drawn for DNA testing to determine what form of kinase is present. An electrocardiogram will also be done if a recent one is not available. Some people may also have an echocardiogram, an ultrasound test to image the heart.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 1999
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 5, 1999
CompletedFirst Submitted
Initial submission to the registry
July 18, 2006
CompletedFirst Posted
Study publicly available on registry
July 19, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2007
CompletedJuly 2, 2017
December 10, 2007
July 18, 2006
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Afro-American patients with a history of hypertension
- Age greater than or equal to 21 years old
- Presence of the kinase allele (homo or heterozygous)
- Ability to give informed consent.
- All of the above as well as:
- Left ventricular ejection fraction of less than 35% by any imaging technique.
You may not qualify if:
- For subjects with Kinase Allele:
- For Subjects without the kinase allele and Myopathy Cohort:
- History of myocardial infarction
- History of significant valve disease
- History of primary hyperthropic or infiltrative cardiomyopathy
- History of rheumatic heart disease
- Chronic atrial arrhythmia, bundle branch block intraventricular conduction defect or definite myocardial infarction on EKG
- Inability to perform a metabolic stress test
- Inability to perform a cMRI
- Poor echocardiographic windows precluding accurate analysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maryland, Baltimore
Baltimore, Maryland, 21201-1595, United States
Related Publications (1)
Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072-83. doi: 10.1161/01.cir.58.6.1072.
PMID: 709763BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 18, 2006
First Posted
July 19, 2006
Study Start
October 5, 1999
Study Completion
December 10, 2007
Last Updated
July 2, 2017
Record last verified: 2007-12-10